Astellas Plots Near-Term Moves to Execute Long-Term Vision in Gene Therapy

A VPN is an essential component of IT security, whether you’re just starting a business or are already up and running. Most business interactions and transactions happen online and VPN

Astellas has become an active player in gene therapy. MedCity News caught up with company executive Richard Wilson, who explained Astellas’s strategy, the clinical holds on its two most advanced programs, and the rationale behind its recent gene therapy deals.

Leave a Replay

Sign up for our Newsletter

Contact Us